Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
BRIEF-Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau Oct 7 (Reuters) - Synthaverse SA SVEP.WA:
RECEIVES REGISTRATION CERTIFICATE FOR ONKO BCG IN PARAGUAY UNDER PARTNERSHIP WITH BLAU
PARAGUAY REGISTRATION ENABLES FURTHER STEPS TO START SUPPLIES AND DISTRIBUTION OF THE PRODUCT
Source text: ID:nEMbxgC5Da
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility